Streetbeat News

Products Services

RCKT

Rocket Pharmaceuticals has received FDA Fast Track and Orphan Drug Designations for its RP-A601 gene therapy for PKP2 Arrhythmogenic Cardiomyopathy. This will expedite the development and review process for the therapy.

Portfolio Pulse from Benzinga Newsdesk

June 08, 2023 | 11:01 am

TSLA

Tesla is considering building a car factory in Spain, according to Cinco Dias. The electric vehicle manufacturer is reportedly in negotiations to establish a production facility in Valencia.

Portfolio Pulse from Charles Gross

June 08, 2023 | 10:53 am

MRK

The FDA has accepted Merck's sBLA for KEYTRUDA in combination with chemotherapy for the treatment of advanced or unresectable biliary tract cancer. The application is based on the KEYNOTE-966 trial, which showed a significant improvement in overall survival compared to chemotherapy alone.

Portfolio Pulse from Benzinga Newsdesk

June 08, 2023 | 10:47 am

FXI

LCID

Lucid Motors plans to sell imported cars in China and is considering local production, according to a person familiar with the matter.

Portfolio Pulse from Charles Gross

June 08, 2023 | 10:46 am

AAPL

Apple's mixed reality headset, Vision Pro, has received positive reviews but raised concerns about comfort due to its heavyweight build and red marks left on users' faces after extended use. Apple acknowledged the issue and assured more options would be available when the product is officially released.

Portfolio Pulse from Ananya Gairola

June 08, 2023 | 10:41 am

MU

Micron Technology has filed a U.S. patent application #20230176739 for an Artificial Intelligence (AI) accelerator, potentially enhancing its product offerings in the AI market.

Portfolio Pulse from Charles Gross

June 08, 2023 | 9:47 am

TSLA

Tesla filed five patent applications on Thursday, covering areas such as interactive air vent control, vehicle summoning, scalable matrix node engine, data synthesis for autonomous control systems, and permanent magnet motor technology.

Portfolio Pulse from Charles Gross

June 08, 2023 | 9:32 am

KZIA

Kazia Therapeutics (NASDAQ:KZIA) is supporting the University of Sydney in a phase II clinical study to investigate paxalisib in patients with recurrent/progressive IDH-mutant grade 2 and 3 glioma. The study, LUMOS2, will be sponsored by the University of Sydney and coordinated by NHMRC Clinical Trials Centre.

Portfolio Pulse from Charles Gross

June 08, 2023 | 9:23 am

TSLA

Tesla has updated its US website to display the starting prices of Model 3 and Model Y vehicles after federal tax credits, highlighting their affordability. The Model 3 now starts at $32,740 and Model Y at $39,990 after credits. All versions of the Tesla Model 3 are now eligible for a full tax credit.

Portfolio Pulse from Anan Ashraf

June 08, 2023 | 9:19 am

AAPL

GOOG

GOOGL

MSFT

Apple introduced a passkey API for iOS 17 at this year's WWDC, following Google's lead in moving towards a password-free future. The Passkey API allows password managers like 1Password to create and use passkeys within native apps, offering a more secure and seamless user experience.

Portfolio Pulse from Ananya Gairola

June 08, 2023 | 5:57 am